KLF4 activates LATS2 to promote cisplatin sensitivity in ovarian cancer through DNA damage. Ma L, Zhao X, Lu X, Shen J, et al. Anticancer Drugs 2024 Sep 27. doi: 10.1097/CAD.0000000000001662.

Read + Share

Amedeo Smart

Independent Medical Education

Ma L, Zhao X, Lu X, Shen J, et al. KLF4 activates LATS2 to promote cisplatin sensitivity in ovarian cancer through DNA damage. Anticancer Drugs 2024 Sep 27. doi: 10.1097/CAD.0000000000001662.
PMID: 39365847